PTEN expression is upregulated by a RNA-binding protein RBM38 via enhancing its mRNA stability in breast cancer

Abstract

BackgroundPTEN (phosphatase and tensin homolog gene on chromosome 10), a well-characterized tumor suppressor, is a key regulator of the phosphatidylinositol-3-kinase (PI3K)/AKT pathway involved in cell survival, metastasis and cell renewal. PTEN expression is closely related to the phenotype, prognosis and drug selection in breast cancer. It is mainly regulated by transcriptional and post-transcriptional modifications. RNA binding motif protein 38 (RBM38), an RNA-binding protein (RBP) and a target of P53 family, plays a crucial role in the regulation of cellular processing, especially in post-transcription regulation and gene transcription. In this study, we investigated a new post-transcription regulation mechanism of PTEN expression by RBM38 in breast cancer.MethodsImmunohistochemistry, lentivirus transfections, Western blotting analysis, qRT-PCR and ELISA were used to conduct the relation between RBM38 and PTEN. RNA immunoprecipitation, RNA electrophoretic mobility shift and dual-luciferase reporter assays were employed to identify the direct binding sites of RBM38 with PTEN transcript. Colony formation assay was conducted to confirm the function of PTEN in RBM38-induced growth suppression.ResultsPTEN expression was positively associated with the expression of RBM38 in breast cancer tissues and breast cancer cells. Moreover, RBM38 stabilized PTEN transcript to enhance PTEN expression via binding to multiple AU/U- rich elements (AREs) in 3′-untranslated region (3′-UTR) of PTEN transcript. Additionally, specific inhibitors of PTEN activity and small interfering (siRNA) of PTEN expression inhibited RBM38-mediated suppression of proliferation, which implied that RBM38 acted as a tumor suppressor partly by enhancing PTEN expression.ConclusionThe present study revealed a new PTEN regulating mechanism that PTEN was positively regulated by RBM38 via stabilizing its transcript stability, which in turn alleviated RBM38-mediated growth suppression.Electronic supplementary materialThe online version of this article (10.1186/s13046-017-0620-3) contains supplementary material, which is available to authorized users.

Exosomal Long Noncoding Rna AGAP2-AS1 Regulates Trastuzumab Resistance via Inducing Autophagy in Breast Cancer

“…differential INSR splicing in molecular subtypes of BC cells and affects cell aggressiveness [12]. And RNAbinding protein RBM38 increases PTEN expression via enhancing its mRNA stability in BC [13].Those studies along with ours indicate that lncRNAs are critical regulators for trastuzumab resistanceby binding with RBPs.…”

Circular RNA (circ‐0075804) promotes the proliferation of retinoblastoma via combining heterogeneous nuclear ribonucleoprotein K (HNRNPK) to improve the stability of E2F transcription factor 3 E2F3

“…For example, Nujiangexathone A suppresses cell growth by targeting HNRNPK in cervical cancer 31 . DAB2IP depletion facilitates cell metastasis in colorectal cancer by translocating HNRNPK into the nucleus and activates MMP2 transcription 32 . Our study demonstrated that HNRNPK could bind with circ‐0075804 and positively regulated the E2F3 expression in RB.…”

Genomic analyses of flow-sorted Hodgkin Reed-Sternberg cells reveal complementary mechanisms of immune evasion

“…7,10,22,[50][51][52] RBM38 encodes an RNA-binding protein and a reported tumor suppressor that modulates gene expression by binding to adenylate-uridylate/uridylate-rich elements in the 39 untranslated region of target transcripts. [53][54][55] Of interest, murine Rbm38 deficiency promotes accelerated aging and lymphomagenesis, in part by destabilizing PTEN transcripts and decreasing PTEN protein expression. 55,56 In 17% of analyzed cHLs, there are previously unreported truncating or missense mutations of RBM38 ( Figure 1A,D).…”